PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Paul Rennie interviewed on Marcus Today Podcast., page-28

  1. 822 Posts.
    lightbulb Created with Sketch. 328
    or 5. The American Markets are on the edge and people are getting out early.

    So many short-term investors (I use the term investor lightly) throw their toys out of the cot just because the US sneezes. Failing material news PAR will be back down on a US tanking (which is not logical but thats what will happen). We are just a cork bobbing in the ocean until material news hits to rerate us. That going to take a deal or approval where revenue is forthcomming otherwise we will continue to bob.

    For many 3 years to registration is just too long so I think any news that speeds up time to market will be good. Based of Pauls recent comments that they are looking to open more centres to reduce the testing timeframe. Personally I think the additional centres may be to help with the confirmatory study as we could have exhausted our trial participants from the existing centres due to the tight controls on who they let in.

    Should be an interesting 6 months as we see if they can get FDA believing the DMOAD story and potentially that will remove the need to finalise the confirmatory study before approving. time will tell.

    The Pool
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
31.0¢
Change
0.035(12.7%)
Mkt cap ! $108.4M
Open High Low Value Volume
27.5¢ 31.0¢ 27.5¢ $108.9K 371.2K

Buyers (Bids)

No. Vol. Price($)
1 1000 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 17420 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.